Analysis of the Molecular Mechanism of Acute Coronary Syndrome Based on circRNA-miRNA Network Regulation

Table 1

Patients characteristics ( group = 5).

	CG	UAP	AMI
Age (years)	55 ± 11	60 ± 11	54 ± 8
HR (min)	66 ± 9	71 ± 13	81 ± 10
SBP (mmHg)	149 ± 10	146 ± 11	130 ± 15
DBP (mmHg)	83 ± 12	79 ± 16	75 ± 6
Glu (3.9–6.1 mmol/L)	5.25 ± 7.82	5.34 ± 0.62	6.46 ± 1.92
CHO (0–5.2 mmol/L)	3.69 ± 0.88	3.99 ± 1.05	3.81 ± 0.37
TG (0.7–1.7 mmol/L)	1.26 ± 0.65	1.21 ± 0.41	1.27 ± 0.45
APOA1 (1–1.76 g/L)	1.13 ± 0.20	1.00 ± 0.10	0.89 ± 0.12
APOB (0.6–1.14 g/L)	0.72 ± 0.20	0.79 ± 1.84	0.71 ± 0.15
HDL (0.8–1.55 mmol/L)	1.11 ± 0.18	0.92 ± 0.20	0.95 ± 0.12
LDL(1.64–3.62 mmol/L)	2.25 ± 0.66	2.54 ± 0.92	2.52 ± 0.44
AST (15–50 U/L)	21.60 ± 4.98	25.60 ± 4.22	96.80 ± 65.06
LDH (313–618 U/L)	149.20 ± 17.20	162.60 ± 29.59	449.00 ± 265.70
CK (55–170 U/L)	48.00 ± 13.21	70.80 ± 35.09	817.60 ± 535.16
CK-MB (0–25 U/L)	15.80 ± 7.22	16.80 ± 4.23	74.40 ± 48.55
Gensini score (%)	1.00 ± 1.41	65.40 ± 49.09	51.90 ± 10.37

APOA1 = apolipoprotein A1; APOB = apolipoprotein B; CHO = total cholesterol; HDL = high-density lipoprotein; LDL = low-density lipoprotein; AST = aspartate transaminase; LDH = lactate dehydrogenase; CK = creatine kinase; CK-MB = creatine kinase isoenzyme MB.